Product correctly added to cart.

discount label
3,5-Dibromo-1-methylpyrazin-2(1H)-one
View 3D

Biosynth logo

3,5-Dibromo-1-methylpyrazin-2(1H)-one

CAS: 87486-34-8

Ref. 3D-FD42437

1gTo inquire
2gTo inquire
5gTo inquire
10gTo inquire
500mgTo inquire
Estimated delivery in United States, on Monday 13 Jan 2025

Product Information

Name:
3,5-Dibromo-1-methylpyrazin-2(1H)-one
Description:

3,5-Dibromo-1-methylpyrazin-2(1H)-one is an anti-influenza drug with a novel chemical structure. It has been shown to inhibit influenza virus replication in vitro and in vivo. 3,5-Dibromo-1-methylpyrazin-2(1H)-one binds to the ribonucleotide reductase enzyme, which is essential for viral RNA synthesis. The molecular weight of this compound is 683 g/mol. 3,5-Dibromo-1-methylpyrazin-2(1H)-one was found to be active against both influenza A and B viruses. This agent also exhibits activity against other RNA viruses, such as herpes simplex virus type 1 and 2 (HSV).

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
267.91 g/mol
Formula:
C5H4Br2N2O
Purity:
Min. 95%
InChI:
InChI=1S/C5H4Br2N2O/c1-9-2-3(6)8-4(7)5(9)10/h2H,1H3
InChI key:
InChIKey=LNVJQIHAUHVGEV-UHFFFAOYSA-N
SMILES:
Cn1cc(Br)nc(Br)c1=O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FD42437 3,5-Dibromo-1-methylpyrazin-2(1H)-one

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".